Cargando…
Elevated expression of TUBA1C in breast cancer predicts poor prognosis
α1C-tubulin (TUBA1C) is a member of the α-tubulin family and has served as a potential biomarker in a variety of cancers in many studies. In this study, the gene expression profile of TUBA1C in The Cancer Genome Atlas (TCGA) was extracted for analysis, and the prognostic value of TUBA1C in breast ca...
Autores principales: | Zhao, Yi, Wang, Wenwen, Li, Jinming, Du, Jiarui, Xie, Qiqi, Wang, Miaozhou, Liu, Zhen, Huo, Xingfa, Zhao, Fuxing, Ren, Dengfeng, Zhao, Jiuda, Shen, GuoShuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688681/ https://www.ncbi.nlm.nih.gov/pubmed/38032902 http://dx.doi.org/10.1371/journal.pone.0263710 |
Ejemplares similares
-
Treatment options for patients with human epidermal growth factor 2-positive breast cancer brain metastases: A systematic review and meta-analysis
por: Huo, Xingfa, et al.
Publicado: (2023) -
Comparing Biomarkers for Predicting Pathological Responses to Neoadjuvant Therapy in HER2-Positive Breast Cancer: A Systematic Review and Meta-Analysis
por: Zhao, Fuxing, et al.
Publicado: (2021) -
Meta-Analysis of HER2-Enriched Subtype Predicting the Pathological Complete Response Within HER2-Positive Breast Cancer in Patients Who Received Neoadjuvant Treatment
por: Shen, Guoshuang, et al.
Publicado: (2021) -
The association between HER2-low expression and prognosis of breast
cancer: a systematic review and meta-analysis
por: Tang, Yuyao, et al.
Publicado: (2023) -
Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis
por: Xin, Yuanfang, et al.
Publicado: (2021)